Biotech firm raises USD 80m for pharmaceutically treating hearing loss
US-based Pipeline Therapeutics has raised USD 80m to be put towards developing a pharmaceutical treatment against hearing loss.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
A series of new institutional investors are so confident about one particular drug candidate for treating hearing loss from biotech firm Pipeline Therapeutics that they, alongside existing investors, have posted USD 80m in the San Diego-based company.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
